50 employees
PhaseRx is a startup company focused on the delivery of siRNA and other macromolecular therapeutics for the treatment of orphan diseases.
2006
$20M
from 3 investors over 3 rounds
PhaseRx raised $20M on February 28, 2008
Investors: 5AM Ventures, ARCH Venture Partners and Versant Ventures